| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 36.108 | 39.635 | 33.973 | 34.055 | 26.614 | 30.529 | 35.760 | 45.502 | 68.616 | 82.666 |
| Total Income - EUR | 36.109 | 39.637 | 33.981 | 34.133 | 26.765 | 30.634 | 35.878 | 45.604 | 68.890 | 83.046 |
| Total Expenses - EUR | 23.869 | 24.794 | 22.209 | 24.830 | 25.730 | 27.249 | 32.958 | 40.737 | 54.048 | 81.200 |
| Gross Profit/Loss - EUR | 12.240 | 14.843 | 11.771 | 9.302 | 1.035 | 3.385 | 2.919 | 4.866 | 14.842 | 1.846 |
| Net Profit/Loss - EUR | 11.156 | 13.654 | 10.752 | 8.279 | 232 | 2.523 | 1.865 | 3.654 | 12.918 | 1.595 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Psi Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 3.894 | 2.762 | 1.645 | 565 | 0 | 0 | 0 | 755 | 715 | 235 |
| Current Assets | 13.511 | 11.398 | 9.527 | 18.672 | 12.294 | 11.553 | 10.218 | 11.614 | 21.375 | 22.587 |
| Inventories | 0 | 6 | 6 | 6 | 11 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 3.765 | 2.579 | 2.769 | 2.348 | 1.697 | 2.687 | 3.057 | 2.894 | 10.136 | 0 |
| Cash | 9.746 | 8.812 | 6.752 | 16.317 | 10.586 | 8.866 | 7.161 | 8.719 | 11.239 | 22.587 |
| Shareholders Funds | 14.811 | 13.729 | 10.807 | 15.234 | 12.010 | 11.204 | 9.788 | 8.200 | 21.094 | 22.571 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.593 | 431 | 366 | 4.003 | 284 | 349 | 429 | 4.168 | 997 | 251 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Psi Med Srl